BioSpace News Archive

Drug Development

Exelixis Announces Encouraging Results from Expansion Cohort of Phase 1b STELLAR-001 Trial Evaluating Zanzalintinib in Patients with Advanced Kidney Cancer at IKCS 2023

Exelixis, Inc. (Nasdaq: EXEL) today announced initial results from an expansion cohort of STELLAR-001 evaluating single-agent zanzalintinib in patients with previously treated clear cell renal cell carcinoma (ccRCC).

November 10, 2023
·
17 min read
BioCapital

Novavax to Participate in Jefferies 2023 London Healthcare Conference

Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, announced that it will participate in the Jefferies London Healthcare Conference.

November 10, 2023
·
1 min read
Digital Therapeutics Market Size, Share, CAGR, Report Forecast 2023 – 2032

According to Vision Research Reports, the global digital therapeutics market size was surpassed at USD 3.91 billion in 2022 and is expected to hit around USD 25.32 billion by 2032, growing at a CAGR of 20.54% from 2023 to 2032.

November 10, 2023
·
7 min read
Policy

STADA and Alvotech receive positive CHMP opinion for Europe’s first ustekinumab biosimilar to Stelara

Partners STADA and Alvotech announced that the Committee for Medicinal Products for Human Use within the European Medicines Agency has adopted a positive opinion for Uzpruvo, a biosimilar candidate to Stelara®.

November 10, 2023
·
10 min read
Live Cell Imaging Market Size to Garner Around USD 5.74 Billion by 2032

The global live cell imaging market size is estimated to garner around USD 5.74 billion by 2032 and is growing at a CAGR of 8.3% from 2023 to 2032.

November 10, 2023
·
10 min read
Drug Development

Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood Cancers

In a breakthrough for human milk science, researchers at City of Hope, Los Angeles, have dosed the first patient in a Phase 2a clinical trial evaluating a novel therapy for blood cancer patients undergoing allogeneic hematopoietic stem cell transplantation.

November 10, 2023
·
5 min read
Pharm Country

PsychoGenics Launches an Updated Corporate Identity and Brand

PsychoGenics Inc., the leading contract research organization specializing in central nervous system focused preclinical and translational drug discovery services, is proud to unveil its refreshed corporate identity and brand.

November 10, 2023
·
2 min read
Sequana Medical announces results of Extraordinary General Meeting of Shareholders - November 10, 2023

Sequana Medical NV announces that all proposed resolutions submitted to the Extraordinary General Meeting of Shareholders were approved at the meeting held today at 09:00 am CET.

November 10, 2023
·
5 min read
Bio NC

Target RWE Releases Important Updates on the Cirrhosis Quality Collaborative/TARGET-Liver Disease Partnership with the American Association for the Study of Liver Diseases

Real-world evidence (RWE) leader Target RWE announced today that the CQC and TARGET-Liver Disease (LD) partnership with the American Association for the Study of Liver Diseases (AASLD) has enrolled approximately 75,000 patients.

November 10, 2023
·
3 min read
Biotech Bay

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 10, 2023

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced, as required by Nasdaq Stock Market rules, the grant of inducement awards to two new employees.

November 10, 2023
·
1 min read